LRMR stock

Analysts review Larimar Therapeutics Inc’s rating
Anna Perez
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul ...

Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul ...